Who is sponsoring NCT04995744?

NCT04995744 is sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization.

What drugs are being tested in NCT04995744?

Interventions in NCT04995744: Pectoralis Major Pedicle Bone Graft.

What condition does NCT04995744 study?

NCT04995744 studies Patients With Closed Neer Type 4 Proximal Humerus Fractures.

Is NCT04995744 still recruiting?

NCT04995744 is currently completed. Last updated 9 August 2021.

Last reviewed 2021-08-09 · How we verify

NCT04995744

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pectoralis Major Pedicle Bone Graft For 4-Part Proximal Humerus Fractures

Completed NA Last updated 9 August 2021

What this trial tests

NA trial testing Pectoralis Major Pedicle Bone Graft in Patients With Closed Neer Type 4 Proximal Humerus Fractures in 17 participants. Completed in 1 February 2020.

Timeline

1 January 2017

Primary endpoint
30 January 2020

1 February 2020

Quick facts

Lead sponsor	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	1 January 2017
Primary completion	30 January 2020
Estimated completion	1 February 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Pectoralis Major Pedicle Bone Graft

Conditions studied

Patients With Closed Neer Type 4 Proximal Humerus Fractures — all drugs for Patients With Closed Neer Type 4 Proximal Humerus Fractures →

Sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Who can join

Adults 50 to 75, any sex, with Patients With Closed Neer Type 4 Proximal Humerus Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators tried to evaluate the results of our patients who underwent plate osteosynthesis with vascularized pectoralis major graft for the treatment of 4-part proximal humerus fractures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization trials

Trials by the same sponsor.

NCT07500285 — Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Ph · Phase 2 · not yet recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07390279 — Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia · recruiting
NCT07357922 — Serum Progesterone and Threatened Abortion During Lactation · not yet recruiting
NCT07283250 — Development and Validation of the Air Quality Awareness Scale (AQAS) for Parents · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04995744 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Last refreshed: 9 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04995744.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing